Pharmaceuticals
Mylan to pay $465 mn to settle DoJ probe over EpiPen costs
08 Oct 2016
Generic and specialty pharmaceuticals company Mylan NV yesterday agreed to pay $465 million to settle allegations of overcharging the US government on its Medicaid program for its EpiPen products
J&J warns of hack flaw in insulin pump, calls risk ‘extremely low’
06 Oct 2016
Johnson & Johnson is warning patients that it has learned of a security vulnerability in one of its insulin pumps that a hacker could exploit to overdose diabetic patients with insulin
Japanese biologist Yoshinori Ohsumi wins 2016 Nobel for Medicine
03 Oct 2016
Yoshinori Ohsumi's elucidation of `autophagy’, a fundamental process for degrading and recycling cellular components, has helped in the understanding of how the cell recycles its content as also the many physiological processes, such as in the adaptation to starvation or response to infection
EpiPens in UK sold for 10% of US prices
30 Sep 2016
